Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006911 | 12600691 | 1 | I | 20160722 | 20160727 | 20160727 | EXP | ES-ABBVIE-16P-144-1686778-00 | ABBVIE | SALA-PADR? J, TOLEDO M, SANTAMARINA E, ET AL. LEVETIRACETAM AND VALPROATE RETENTION RATE IN JUVENILE MYOCLONIC EPILEPSY. CLINICAL NEUROPHARMACOLOGY. 2016 JUL 19;. | 0.00 | Y | 0.00000 | 20160727 | MD | COUNTRY NOT SPECIFIED | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006911 | 12600691 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Transplacental | UNKNOWN | 18081 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126006911 | 12600691 | 1 | Maternal exposure timing unspecified |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126006911 | 12600691 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126006911 | 12600691 | Foetal exposure during pregnancy | |
| 126006911 | 12600691 | Heart disease congenital |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |